Cargando…

Cancer prevention through weight control—where are we in 2020?

Growing data from epidemiological studies highlight the association between excess body fat and cancer incidence, but good indicative evidence demonstrates that intentional weight loss, as well as increasing physical activity, offers much promise as a cost-effective approach for reducing the cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Annie S., Renehan, Andrew G., Saxton, John M., Bell, Joshua, Cade, Janet, Cross, Amanda J., King, Angela, Riboli, Elio, Sniehotta, Falko, Treweek, Shaun, Martin, Richard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960959/ https://www.ncbi.nlm.nih.gov/pubmed/33235315 http://dx.doi.org/10.1038/s41416-020-01154-3

Ejemplares similares

Cancer survivorship, excess body fatness and weight-loss intervention—where are we in 2020?
por: Anderson, Annie S., et al.
Publicado: (2020)

Mathematics anxiety—where are we and where shall we go?
por: Cipora, Krzysztof, et al.
Publicado: (2022)

Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to
por: Carofiglio, Francesca, et al.
Publicado: (2020)

Natural Products and Synthetic Biology: Where We Are and Where We Need To Go
por: Kunakom, Sylvia, et al.
Publicado: (2019)

Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)

50 Years of Women in Cell Biology: Where have we been? Where are we going?
por: Masur, Sandra K., et al.
Publicado: (2021)

Drug Design: Where We Are and Future Prospects
por: Zagotto, Giuseppe, et al.
Publicado: (2021)

Automated clinical coding: what, why, and where we are?
por: Dong, Hang, et al.
Publicado: (2022)

Breast cancer causes and treatment: where are we going wrong?
por: Seymour, Colin B, et al.
Publicado: (2013)

COVID toes: where do we stand with the current evidence?
por: Baeck, Marie, et al.
Publicado: (2021)

Women in neuroscience: Where are we in 2019?
por: Machlovi, Saima, et al.
Publicado: (2020)

Combating antiscience: Are we preparing for the 2020s?
por: Hotez, Peter J.
Publicado: (2020)

Epigenetics studies of fetal alcohol spectrum disorder: where are we now?
por: Lussier, Alexandre A, et al.
Publicado: (2017)

FDG-PET/CT in Lymphoma: Where Do We Go Now?
por: Al Tabaa, Yassine, et al.
Publicado: (2021)

Toward a genome sequence for every animal: Where are we now?
por: Hotaling, Scott, et al.
Publicado: (2021)

Preventing Retinal Detachment: Where are We? Implications from Stickler Syndrome
por: Morris, Robert E, et al.
Publicado: (2022)

MR-Guided Focused Ultrasound for Refractory Epilepsy: Where Are We Now?
por: Labate, Angelo, et al.
Publicado: (2023)

Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?
por: Renke, Guilherme, et al.
Publicado: (2023)

The evolution of bacterial genome assemblies - where do we need to go next?
por: Altermann, Eric, et al.
Publicado: (2022)

Editorial: The Future of Environmental Medicine in Environmental Health Perspectives: Where Should We Be Headed?
por: Schwartz, Brian S., et al.
Publicado: (2005)

Location, Location, Location: Where We Teach Primary Care Makes All the Difference
por: Cassel, Christine, et al.
Publicado: (2017)

Heritage Conservation Future: Where We Stand, Challenges Ahead, and a Paradigm Shift
por: Otero, Jorge
Publicado: (2021)

Neurointervention in the 2020s: Where are We Going?
por: Goyal, Mayank, et al.
Publicado: (2020)

MHC Restriction: Where Are We Now?
por: Zareie, Pirooz, et al.
Publicado: (2020)

Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?
por: Xue, Fang, et al.
Publicado: (2023)

Deep Brain Stimulation for Addictive Disorders—Where Are We Now?
por: Yuen, Jason, et al.
Publicado: (2022)

The cancer-obesity connection: what do we know and what can we do?
por: Riboli, Elio
Publicado: (2014)

Caffeine in preterm infants: where are we in 2020?
por: Moschino, Laura, et al.
Publicado: (2020)

Implantable Hearing Aids: Where are we in 2020?
por: Banakis Hartl, Renee M., et al.
Publicado: (2020)

Pharmacological treatments for PTSD: where are we in 2020?
por: Bui, Eric
Publicado: (2021)

CUREs in biochemistry—where we are and where we should go
por: Bell, Jessica K., et al.
Publicado: (2016)

Nusinersen and Spinal Muscular Atrophies: Where are we in 2020?
por: Khadilkar, Satish V., et al.
Publicado: (2020)

Developmental Programming of Obesity and Diabetes in Mouse, Monkey, and Man in 2018: Where Are We Headed?
por: Friedman, Jacob E.
Publicado: (2018)

Male contraception: where are we going and where have we been?
por: Reynolds-Wright, John Joseph, et al.
Publicado: (2019)

Dietary Nitrate: Where Is the Risk?
por: L’hirondel, Jean-Louis, et al.
Publicado: (2006)

Bisphenol A: Where to Now?
por: Bucher, John R.
Publicado: (2009)

Where Next for Genetics and Genomics?
por: Tyler-Smith, Chris, et al.
Publicado: (2015)

Where Next for Microbiome Research?
por: Waldor, Matthew K., et al.
Publicado: (2015)

Supporting postpartum weight loss in women living in deprived communities – design implications for a randomised control trial
por: Craigie, Angela M., et al.
Publicado: (2011)

Historical Perspective: S. Leonard Syme's influence on the development of social epidemiology and where we go from there
por: Yen, Irene H
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_g17pge6f9rs7aq3q97t8i9ppo2